We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
How to report incidents, including pro-formas for PON1 and PON2 and guidance on completion; listing of environmental alerts for operators in the North Sea.
Advice on writing clear notices and maximising replies to your FSNs.
Lists of standards that businesses can use to show their products, services or processes comply with essential requirements of legislation.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
Get help to classify electric lamps for import and export.
Licence and registration application information for companies that deal in precursor chemicals.
Find out which radioactive sources you need a licence to export and how to apply for one.
Guidance for suppliers and dealers.
Interested parties can review records of applications and statements submitted to OPRED as required by environmental regulations.
Find out if you will need to use the new UKNI marking and how to use it.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Advises on how to consider light within the planning system.
Dose of nicotine delivered & uptake and consistency of dose.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Explains control of advertisement regime.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.